Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin

The Dialysis Patients Response to IV Iron with Elevated Ferritin (DRIVE) study demonstrated the efficacy of intravenous ferric gluconate to improve hemoglobin levels in anemic hemodialysis patients who were receiving adequate epoetin doses and who had ferritin levels between 500 and 1200 ng/ml and t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kapoian, Toros, O'Mara, Neeta B., Singh, Ajay K., Moran, John, Rizkala, Adel R., Geronemus, Robert, Kopelman, Robert C., Dahl, Naomi V., Coyne, Daniel W.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2008
Teme:
Clinical Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2396742/
https://ncbi.nlm.nih.gov/pubmed/18216316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007050606
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items